The European Parliament (EP) has published two draft reports on the Commission’s proposals for a new Pharmaceutical Regulation and Directive. The reports have been…
- Polish HTA and Reimbursement Shake Up Creates Potential Ambiguity For Industry in Face of EU Pharma Package
- EU Standard Clauses for AI Procurement: 5 Takeaways for Pharma and Medtech
- UK Aesthetics Sector Regulatory Shake Up
- Reverse-Payment Patent Settlements in the Pharmaceutical Sector: the EU General Court puts the Final Nail in the Coffin
- AI for Health: Regulatory Considerations Published by the WHO
- EU Pharma Package: EP Rapporteurs Have Opposing Views on the New Pharmaceutical Directive and Regulation
- Spanish Judgment May Shorten Price and Reimbursement Procedures for Medicines
- CJEU Confirms Prohibition on Wholesalers Purchasing Medicines From Pharmacies Lacking a WDA
In brief On 26 June 2023, the Spanish National Court annulled the evaluation system of newly approved medicinal products based on Therapeutic Positioning Reports…
CJEU Confirms Prohibition on Wholesalers Purchasing Medicines From Pharmacies Lacking a WDA
The Court of Justice of the European Union (CJEU) has recently issued a judgment clarifying that wholesale distributors may not obtain medicines directly from…
Today the European Commission has finally published its Proposal to revise the EU Pharmaceutical legislation, the most momentous…
On 26 April 2023 the European Commission published its Proposals to Reform the EU pharmaceutical legislation.[1] We continue…
In brief Reimbursing medicinal products is critical to ensure that treatments are widely available to patients. This is…
The Proposal to revise the EU Pharmaceutical legislation has generated unprecedented levels of attention, not only across the…
As previously covered in this blog, on 26 April 2023 the European Commission published a set of proposals…
As already well noted on this blog, on 26 April 2023 the European Commission published a set of…